Malignant Mesothelioma Patients Likely To Benefit From Drug Pemetrexed Identified By Study

Previous studies have hypothesized that low levels of the enzyme thymidylate synthase (TS) likely mark patients who will benefit from the drug pemetrexed – but results have been inconclusive at best…